| View |
|
DRP-11481-01
|
Cefotaxime (as sodium)
|
Quxime
|
1 g
|
Powder for Injection (I.M./I. V .)
|
Antibacterial
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
03 August 2022
|
16 March 2027
|
| View |
|
DRP-12409
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
Levomont
|
10 mg / 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/Antihistamine
|
Theon Pharmaceuticals Limited
|
India
|
PCPR Conversion
|
02 August 2022
|
01 September 2025
|
| View |
DRP-5599-01_PI_01.pdf
|
DRP-5599-01
|
Cloxacillin (as Sodium)
|
Cloxin
|
500mg
|
Capsule
|
Antibacterial
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
01 August 2022
|
04 January 2027
|
| View |
|
DRP-11154-09
|
Nicardipine Hydrochloride
|
Nicarvin
|
1mg/mL (10mg/10mL)
|
Solution for Injection (IV Infusion)
|
Calcium Channel Blocker (Dihydropiridine derivative)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
01 August 2022
|
11 February 2027
|
| View |
DRP-460-03_PI_01.pdf
|
DRP-460-03
|
Doxycycline (as Hydrochloride)
|
Doxinex
|
100mg
|
Capsule
|
Antibacterial
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
29 July 2022
|
20 March 2026
|
| View |
|
HRP-128-07
|
Ascorbic Acid
|
Unbranded
|
100 mg/5 mL
|
Syrup
|
Vitamin
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
29 July 2022
|
13 January 2026
|
| View |
|
HRP-220-02
|
Paracetamol
|
Febrolex
|
100mg/mL
|
Syrup (Oral drops)
|
Analgesic/Antipyretic
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
29 July 2022
|
19 May 2027
|
| View |
|
HRP-222-01
|
Paracetamol
|
Febrolex
|
125mg/5mL
|
Syrup
|
Analgesic/Antipyretic
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
29 July 2022
|
13 June 2025
|
| View |
|
DRP-3264-13
|
Paracetamol / Vitamin B1 / Vitamin B6 / Vitamin B12
|
Nervicap Plus
|
500 mg / 50 mg / 100 mg / 100 mcg
|
Film-Coated Tablet
|
Analgesic
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
29 July 2022
|
20 May 2027
|
| View |
|
DRP-4061-07
|
Multivitamins+Dextrose
|
Muldezar
|
25g+250mg+500mg+125mg+25mg+25mg+625mg
|
Solution for Injection
|
Parenteral Nutrition
|
Shijiazhuang No. 4 Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
29 July 2022
|
14 June 2026
|
| View |
|
DRP-4791-05
|
Gabapentin
|
Unbranded
|
100 mg
|
Capsule
|
Anticonvulsant
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
19 October 2022
|
04 October 2028
|
| View |
|
DRP-5324-02
|
Aluminum Hydroxide + Magnesium Hydroxide
|
Gascosid
|
225mg/200mg per 5mL
|
Suspension
|
Antacid
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
29 July 2022
|
14 April 2027
|
| View |
|
DRP-5472-02
|
Multivitamins + Minerals
|
Nicee-Vit
|
(See reverse for formulation)
|
Syrup
|
Vitamins/Minerals
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
22 March 2023
|
17 February 2028
|
| View |
|
DRP-5636-01
|
Paracetamol
|
Febrolex
|
500mg
|
Tablet
|
Analgesic/Antipyretic
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
29 July 2022
|
08 April 2027
|
| View |
|
DRP-6651-03
|
Rosuvastatin (as Calcium)
|
Zyrova
|
5 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Maple Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
29 July 2022
|
22 April 2026
|
| View |
|
DRP-8240-01
|
Terbinafine hydrochloride + Mometasone furoate
|
Momefine
|
10 mg/g (1 % w/w) / 1 mg/g (0.1 % w/w)
|
Cream
|
Antifungal/Corticosteroid
|
Agio Pharmaceuticals Ltd.
|
India
|
Renewal
|
12 June 2024
|
25 June 2029
|
| View |
|
DRP-8707-01
|
Pregabalin
|
Prebaxine
|
75 mg
|
Capsule
|
Antiepileptic
|
Gracure Pharmaceutical Ltd.
|
India
|
CLIDP Conversion
|
29 July 2022
|
07 February 2025
|
| View |
|
DRP-8708-04
|
Esomeprazole
|
EzopMax
|
40 mg
|
Enteric-Coated
|
Proton Pump Inhibitor
|
Gracure Pharmaceutical Ltd.
|
India
|
CLIDP Conversion
|
29 July 2022
|
07 February 2025
|
| View |
|
DRP-8736-01
|
Ketorolac Trometamol
|
Ketonix
|
30 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Non-Steroidal Anti-inflammatory Drug (NSAID)
|
Farbe Firma
|
India
|
CLIDP Conversion
|
29 July 2022
|
17 April 2025
|
| View |
|
DRP-9033-04
|
Levetiracetam
|
Levecare
|
100 mg/mL
|
Oral Solution
|
Antiepileptic
|
Hetero Labs Limited (Unit III)
|
India
|
CLIDP Conversion
|
29 July 2022
|
20 August 2025
|